Australia markets open in 6 hours 24 minutes

Nurosene Health Inc. (8TV.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.2220-0.0100 (-4.31%)
As of 08:11AM CEST. Market open.

Nurosene Health Inc.

1655 Dupont Street
Suite 101
Toronto, ON M6P 3T1
416 859 8838

Sector(s):Β Healthcare
Industry:Β Health Information Services
Full-time employees:Β 

Key executives

NameTitlePayExercisedYear born
Mr. George AchilleosCEO & Pres27.17kN/AN/A
Mr. Daniel GallucciFounder, Chief Innovation Officer & Director67.66kN/A1977
Dr. Joseph Geraci Ph.D.Chief Scientific OfficerN/AN/AN/A
Ms. Jaime HackettVP of MarketingN/AN/AN/A
Dr. Luca Pani M.D.Chief Medical Advisor & Member of Mental Health Advisory CouncilN/AN/AN/A
Dr. Kaveh KavoosiHead of Progressive MedicineN/AN/AN/A
Mr. Mark SmithyesPres of NetraMarkN/AN/A1970
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Nurosene Inc., a technology-driven wellness company, focuses on developing a line of proprietary nutraceuticals in Canada. It develops nutraceuticals, including Nuro Drive, a product to enhance physical and cognitive energy levels; Nuro Restore, a product to improve sleep, as well as reduce stress, and pain and inflammation. The company is also developing a virtual care mobile application to provide continuous support to those suffering from mental health issues. Nurosene Inc. was incorporated in 2019 and is headquartered in Toronto, Canada.

Corporate governance

Nurosene Health Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.